Susceptibility of 100 filamentous fungi: Comparison of two diffusion methods, Neo-Sensitabs and E-test, for amphotericin B, caspofungin, itraconazole, voriconazole and posaconazole

Medical Mycology

Volumn 50, Issue 4, 2012, Pages 378-385

  Colosi, Ioana A ^a   Faure, Odile ^b   Dessaigne, Bérangère ^b   Bourdon, Cécile ^b   Lebeau, Bernadette ^b   Colosi, Horaţiu A ^a   Pelloux, Hervé ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

E test; Filamentous fungi; Neo Sensitabs; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSION; DOSE RESPONSE; EPSILOMETER TEST; FUNGUS ISOLATION; FUSARIUM; IN VITRO STUDY; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MOULD; NEO SENSITAB TABLET DIFFUSION; NONHUMAN; SCEDOSPORIUM; ZYGOMYCETES;

ANTIFUNGAL AGENTS; DIAGNOSTIC ERRORS; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGY; MYCOSES;

ASPERGILLUS; FUNGI; FUSARIUM; SCEDOSPORIUM; ZYGOMYCETES;

EID: 84859784187     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.616543     Document Type: Article

References (24)

1. Kontoyiannis DP, Marr KA, Park BJ, et al . Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001- 2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50 : 1091-1100.
2. Marr KA. Fungal infections in oncology patients: update on epidemiology, prevention, and treatment. Curr Opin Oncol 2010; 22 : 138-42.
3. Pappas PG, Alexander BD, Andes DR, et al . Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50 : 1101-1111.
4. Baddley JW, Marr KA, Andes DR, e t al . Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant- Associated Infection Surveillance Network. J Clin Microbiol 2009; 47 : 3271-3275.
5. Lass-Flörl C. In vitro susceptibility testing in Aspergillus species: an update. Future Microbiol 2010; 5 : 789-799.
6. Clinical and Laboratory Standards Institute (formerly NCCLS). R eference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi , approved standard, 2nd edn. M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
7. Arendrup MC, Perkhofer S, Howard SJ, et al . Establishing i n vitroin vivo correlations for Aspergillus fumigatus : the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 2008; 52 : 3504-3511.
8. Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic fi lamentous fungi. J Clin Microbiol 2001; 39 : 1360-1367. (Pubitemid 32275436)
9. Espinel-Ingroff A, Rezusta A. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol 2002; 40 : 2101-2107. (Pubitemid 34596392)
10. Martos AI, Romero A, González MT, e t al . Evaluation of the E-test method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol 2010; 48 : 858-861.
11. Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol 2003; 41 : 1126-1129. (Pubitemid 36307117)
12. Pfaller MA, Messer SA, Mills K, Bolmström A. In vitro susceptibility testing of fi lamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol 2000; 38 : 3359-3361.
13. Serrano MC, Morilla D, Valverde A, e t al . Comparison of Etest with modifi ed broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole. J Clin Microbiol 2003; 41 : 5270-5272. (Pubitemid 37429958)
14. Serrano MC, Ramírez M, Morilla D, e t al . A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp. J Antimicrob Chemother 2004; 53 : 739-742. (Pubitemid 38678507)
15. Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 1999; 37 : 1480-1483. (Pubitemid 29187822)
16. Clinical and Laboratory Standard Institute/National Committee for Clinical Laboratory Standards. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts , approved guideline M44-A. Wayne, PA: Clinical and Laboratory Standard Institute; 2004.
17. Espinel-Ingroff A. Comparison of three commercial assays and a modifi ed disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 2006; 44 : 3616-3622. (Pubitemid 46768814)
18. Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, et al . Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of fi lamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol 2007; 45 : 1811-1820. (Pubitemid 46933912)
19. Espinel-Ingroff A, Canton E. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk difussion methods for testing susceptibility of fi lamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2008; 46 : 1793-1803. (Pubitemid 351657231)
20. López-Oviedo E, Aller AI, Mart ín C, et al . Evaluation of disk diffusion method for determining posaconazole susceptibility of fi lamantous fungi: comparision with CLSI broth microdilution method. Antimicrob Agents Chemother 2006; 50 : 1108-1111. (Pubitemid 43327823)
21. Messer SA, Diekema DJ, Hollis RJ, e t al . Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of fi lamentous fungi. J Clin Microbiol 2007; 45 : 1322-1324. (Pubitemid 46626507)
22. Espinel-Ingroff A, Diekema DJ, Fothergill A, e t al . Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 Document). J Clin Microbiol 2010; 48 : 3251-3257.
23. Espinel-Ingroff A, Fothergill A, Fuller J, et al . Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 Document). Antimicrob Agents Chemother 2011; 55 : 2855-2859.
24. Espinel-Ingroff A, Fothergill A, Ghannoum M, et al . Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2005: 43 : 5243-5246. This paper was fi rst published online on Early Online on 6 October 2011. (Pubitemid 41484032)